Author Interviews, BMJ, Rheumatology / 03.10.2013
Rheumatoid Arthritis: Fish Oil and Symptomatic Benefit
MedicalResearch.com Interview with
A/Prof Susanna M Proudman MB BS (Hons) FRACP
Discipline of Medicine, University of Adelaide
Senior Consultant in Rheumatology
Royal Adelaide Hospital
North Terrace, Adelaide, 5000
MedicalResearch.com: What are the main findings of the study?
Answer: In patients with early DMARD-naïve rheumatoid arthritis (RA), fish oil (delivering an average daily dose of 3.7 g dose of omega-3 fats) was associated with benefits additional to those achieved by combination treat-to-target DMARDs with similar methotrexate use. These included significantly reduced risk of triple DMARD failure, defined as needing the addition of leflunomide, and a higher rate of ACR remission.
Because a structured treatment algorithm that was responsive to disease activity and tolerance was used, drug use could be used as an outcome measure for the effects of fish oil. This is one of the novel features of this study as the study design allows for a RCT to be performed on a background of treat-to-target therapy for early RA. (more…)